Funder
Innovative Medicines Initiative
Norwegian Research Council
U.S. Department of Health and Human Services
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–98.
2. Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen J-A, Klugman K, Davies S. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(10014):168–75.
3. Silver LL. Challenges of antibacterial discovery. Clin Microbiol Rev. 2011;24(1):71–109.
4. Laxminarayan R. Antibiotic effectiveness: Balancing conservation against innovation. Science. 2014;345(6202):1299–301.
5. Harbarth S, Theuretzbacher U, Hackett J, Adriaenssens N, Anderson J, Antonisse A, Årdal C, Baillon-Plot N, Baraldi E, Bhatti T. Antibiotic research and development: business as usual? J Antimicrob Chemother. 2015;70(6):1604–7.